277 related articles for article (PubMed ID: 22432707)
21. Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.
Liu H; Hu Z; Li M; Yang Y; Lu S; Rao X
J Biomed Sci; 2023 Apr; 30(1):29. PubMed ID: 37101261
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a novel endolysin LysSA11 and its utility as a potent biocontrol agent against Staphylococcus aureus on food and utensils.
Chang Y; Kim M; Ryu S
Food Microbiol; 2017 Dec; 68():112-120. PubMed ID: 28800818
[TBL] [Abstract][Full Text] [Related]
23. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
Becker SC; Foster-Frey J; Donovan DM
FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
[TBL] [Abstract][Full Text] [Related]
24. Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.
Schmelcher M; Shen Y; Nelson DC; Eugster MR; Eichenseher F; Hanke DC; Loessner MJ; Dong S; Pritchard DG; Lee JC; Becker SC; Foster-Frey J; Donovan DM
J Antimicrob Chemother; 2015 May; 70(5):1453-65. PubMed ID: 25630640
[TBL] [Abstract][Full Text] [Related]
25. A novel bacteriophage Tail-Associated Muralytic Enzyme (TAME) from Phage K and its development into a potent antistaphylococcal protein.
Paul VD; Rajagopalan SS; Sundarrajan S; George SE; Asrani JY; Pillai R; Chikkamadaiah R; Durgaiah M; Sriram B; Padmanabhan S
BMC Microbiol; 2011 Oct; 11():226. PubMed ID: 21985151
[TBL] [Abstract][Full Text] [Related]
26. Characterizations of the endolysin Lys84 and its domains from phage qdsa002 with high activities against Staphylococcus aureus and its biofilms.
Ning H; Lin H; Wang J; He X; Lv X; Ju L
Enzyme Microb Technol; 2021 Aug; 148():109809. PubMed ID: 34116743
[TBL] [Abstract][Full Text] [Related]
27. Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.
Briers Y; Lavigne R
Future Microbiol; 2015; 10(3):377-90. PubMed ID: 25812461
[TBL] [Abstract][Full Text] [Related]
28. Combined effect of SAR-endolysin LysKpV475 with polymyxin B and
Gontijo M; Pereira Teles M; Martins Correia H; Pérez Jorge G; Rodrigues Santos Goes IC; Fasabi Flores AJ; Braz M; de Moraes Ceseti L; Zonzini Ramos P; Rosa E Silva I; Pereira Vidigal PM; Kobarg J; Miguez Couñago R; Alvarez-Martinez CE; Pereira C; Freire CSR; Almeida A; Brocchi M
Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739436
[TBL] [Abstract][Full Text] [Related]
29. Complete genome sequence of a newly isolated lytic bacteriophage, EFAP-1 of Enterococcus faecalis, and antibacterial activity of its endolysin EFAL-1.
Son JS; Jun SY; Kim EB; Park JE; Paik HR; Yoon SJ; Kang SH; Choi YJ
J Appl Microbiol; 2010 May; 108(5):1769-79. PubMed ID: 19863688
[TBL] [Abstract][Full Text] [Related]
30. Binding domains of Bacillus anthracis phage endolysins recognize cell culture age-related features on the bacterial surface.
Paskaleva EE; Mundra RV; Mehta KK; Pangule RC; Wu X; Glatfelter WS; Chen Z; Dordick JS; Kane RS
Biotechnol Prog; 2015; 31(6):1487-93. PubMed ID: 26399565
[TBL] [Abstract][Full Text] [Related]
31. Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL.
Briers Y; Volckaert G; Cornelissen A; Lagaert S; Michiels CW; Hertveldt K; Lavigne R
Mol Microbiol; 2007 Sep; 65(5):1334-44. PubMed ID: 17697255
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and Lytic Activity of Phage-Derived Peptidoglycan Hydrolase, LysSAP8, as a Potent Alternative Biocontrol Agent for
Yu JH; Lim JA; Chang HJ; Park JH
J Microbiol Biotechnol; 2019 Dec; 29(12):1916-1924. PubMed ID: 31635440
[TBL] [Abstract][Full Text] [Related]
33. The application of the lytic domain of endolysin from Staphylococcus aureus bacteriophage in milk.
Yan J; Yang R; Yu S; Zhao W
J Dairy Sci; 2021 Mar; 104(3):2641-2653. PubMed ID: 33358804
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus.
Manoharadas S; Witte A; Bläsi U
J Biotechnol; 2009 Jan; 139(1):118-23. PubMed ID: 18940209
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a novel cell wall binding domain-containing Staphylococcus aureus endolysin LysSA97.
Chang Y; Ryu S
Appl Microbiol Biotechnol; 2017 Jan; 101(1):147-158. PubMed ID: 27498125
[TBL] [Abstract][Full Text] [Related]
36. Discovery and Biochemical Characterization of PlyP56, PlyN74, and PlyTB40-
Etobayeva I; Linden SB; Alem F; Harb L; Rizkalla L; Mosier PD; Johnson AA; Temple L; Hakami RM; Nelson DC
Viruses; 2018 May; 10(5):. PubMed ID: 29883383
[TBL] [Abstract][Full Text] [Related]
37. Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain.
Becker SC; Foster-Frey J; Stodola AJ; Anacker D; Donovan DM
Gene; 2009 Aug; 443(1-2):32-41. PubMed ID: 19422893
[TBL] [Abstract][Full Text] [Related]
38. Structural and biochemical insights into the bacteriophage PlyGRCS endolysin targeting methicillin-resistant Staphylococcus aureus (MRSA) and serendipitous discovery of its interaction with a cold shock protein C (CspC).
Krishnappa G; Mandal M; Ganesan S; Babu S; Padavattan S; Haradara Bahubali VK; Padmanabhan B
Protein Sci; 2023 Sep; 32(9):e4737. PubMed ID: 37497650
[TBL] [Abstract][Full Text] [Related]
39. DUF3380 Domain from a Salmonella Phage Endolysin Shows Potent N-Acetylmuramidase Activity.
Rodríguez-Rubio L; Gerstmans H; Thorpe S; Mesnage S; Lavigne R; Briers Y
Appl Environ Microbiol; 2016 Aug; 82(16):4975-81. PubMed ID: 27287318
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the Lytic Capability of a LysK-Like Endolysin, Lys-phiSA012, Derived from a Polyvalent Staphylococcus aureus Bacteriophage.
Fujiki J; Nakamura T; Furusawa T; Ohno H; Takahashi H; Kitana J; Usui M; Higuchi H; Tanji Y; Tamura Y; Iwano H
Pharmaceuticals (Basel); 2018 Feb; 11(1):. PubMed ID: 29495305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
